LISLE, IL, UNITED STATES, January 12, 2026 /EINPresswire.com/ -- OWP Pharmaceuticals today announced commercial product ...
April 26, 2011 — The US Food and Drug Administration has approved lamotrigine extended release for conversion to monotherapy for partial seizures. This is a new indication for the GlaxoSmithKline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results